Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine Supplementation in Rheumatoid Arthritis
NCT06753565Phase 2Recruiting
- Sponsor
- German University in Cairo
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in rheumatoid arthritis (RA), sponsored by German University in Cairo. Started Dec 2024; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06753565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06753565.